ccRCC progression is associated with a Von Hippel–Lindau (VHL) tumor suppressor loss-of-function mutation [5,6], leading to the activation of HIF1 and HIF2, which drive carcinogenesis [7]. This evidence concerns the gene SETD2 and nonpapillary renal cell carcinoma.